MKS Inc. (MKSI) Stock Analysis
Is MKSI a good investment?
MKS Inc. (MKSI) has a Plutrex AI rating of 76.0/100 as of October 05, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: PEG ratio of 1.22 represents a 30.8% discount to the industry average PEG of 1.76 — MKSI trades at the same P/E as average peers (44.51 vs 44.29) but with materially superior forward EPS growth of 33.5-36.5% vs peer average of 28.7-31.8%, creating a genuine growth-adjusted mispricing. Analyst consensus of $345 (23.6% upside) and multiple Wall Street notes citing 49-52% potential upside reinforce this.. Main concern: Debt-to-equity of 0.93 versus industry average of 0.54 (73% more leveraged than peers) is the most critical risk. In a semiconductor equipment downturn — and this sector is notoriously cyclical — MKSI's interest burden (consuming ~10.5% of revenue between operating and net margin vs ~6% for peers) could stress earnings significantly. The ROE of 15.92% being BELOW the peer average of 16.36% despite carrying far more leverage is a quiet warning sign about underlying asset returns..
Investment Summary
MKS Instruments (MKSI) at $279.15 presents a compelling growth story wrapped in a moderately leveraged balance sheet, with all major analytical signals pointing in the same constructive direction. The thesis is straightforward: MKSI trades at a P/E of 44.51x — identical to the peer average of 44.29x — yet carries a PEG of 1.22 versus the industry average of 1.76, a 30.8% growth-adjusted discount. This gap exists because MKSI's forward EPS growth of 33.5% (next year) and 36.5% (5-year CAGR) meaningfully exceeds peers at 28.7% and 31.8% respectively. The gross margin of 41.25% is 51% above the industry average of 27.3%, and operating margin of 20.59% is 45% above the peer average of 14.18% — confirming genuine pricing power and operational discipline. The primary concern is the D/E ratio of 0.93 versus the industry average of 0.54, making MKSI 73% more leveraged than peers in a cyclical sector. FCF of $454M and cash of $611M provide meaningful downside buffers. Analyst consensus of $345 implies 23.6% upside. News flow (sentiment 97/100, 7 positive/1 neutral out of 8 articles) is uniformly constructive: analysts are raising EPS estimates, Wall Street sees 49-52% potential upside, and the Penang expansion is strengthening WFE positioning. The leverage risk is real but manageable given robust FCF generation. Net verdict: a high-quality growth compounder trading at a peer-relative discount — buy on weakness.
Key Strengths
- PEG ratio of 1.22 represents a 30.8% discount to the industry average PEG of 1.76 — MKSI trades at the same P/E as average peers (44.51 vs 44.29) but with materially superior forward EPS growth of 33.5-36.5% vs peer average of 28.7-31.8%, creating a genuine growth-adjusted mispricing. Analyst consensus of $345 (23.6% upside) and multiple Wall Street notes citing 49-52% potential upside reinforce this.
- Gross margin of 41.25% (51% above the 27.3% peer average) and operating margin of 20.59% (45% above the 14.18% peer average) confirm MKSI is not a commodity hardware company — it has genuine pricing power, differentiated IP-rich products, and cost discipline that is structurally superior to the peer group. This margin quality underpins the FCF generation of $454M.
- News catalyst alignment: Analysts are actively revising EPS estimates higher ('Earnings Estimates Moving Higher for MKS (MKSI): Time to Buy?' — positive because upward revisions precede price target increases), the Penang expansion is expanding WFE exposure at a critical time in semiconductor capex cycle, and supplier awards from Zhen Ding Technology signal deepening customer relationships in Asia electronics manufacturing.
Key Concerns
- Debt-to-equity of 0.93 versus industry average of 0.54 (73% more leveraged than peers) is the most critical risk. In a semiconductor equipment downturn — and this sector is notoriously cyclical — MKSI's interest burden (consuming ~10.5% of revenue between operating and net margin vs ~6% for peers) could stress earnings significantly. The ROE of 15.92% being BELOW the peer average of 16.36% despite carrying far more leverage is a quiet warning sign about underlying asset returns.
- The 36.5% 5-year EPS CAGR projection is aggressive and the primary valuation risk. If this decelerates to 18-20% (still strong), the PEG would balloon from 1.22 to approximately 2.2-2.5x at current P/E of 44.51, and the stock would be meaningfully overvalued. The 162% earnings recovery from trough conditions creates a high base effect, and revenue growth already lagging peers (28.3% vs 32.75%) suggests top-line momentum may not fully support the forward EPS trajectory without continued margin expansion.
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
MKSI's fundamentals are a study in contrasts: exceptional operational quality paired with elevated financial leverage. Profitability: Gross margin 41.25% (vs industry 27.3%) and operating margin 20.59% (vs industry 14.18%) demonstrate a differentiated product mix with genuine pricing power — not commodity hardware. Net margin of 10.14% vs operating margin of 20.59% reveals ~10.5% consumed by interest/taxes, materially worse than the peer compression of ~6%, directly reflecting the D/E of 0.93 vs peer average 0.54. ROE of 15.92% sits just below the peer average of 16.36% — a subtle but important signal: despite carrying 73% more debt than peers (which should arithmetically amplify ROE via leverage), MKSI's ROE is still below average, suggesting the underlying return on assets is softer than margins imply. Growth: Revenue growth of 28.3% trails the peer average of 32.75%, but EPS growth of 162% YoY vs peer average of 61.5% confirms powerful operating leverage in the recovery cycle. Forward EPS growth of 33.5% (1yr) and 36.5% (5yr) both exceed peer averages meaningfully. Valuation: P/E of 44.51 at parity with peers (44.29), but PEG of 1.22 vs 1.76 peers = 30.8% growth-adjusted discount. P/B of 6.32 is premium but justified by margin superiority. Financial health: D/E 0.93 is the critical risk; FCF of $454M (strong) and $611M cash partially mitigate but do not eliminate cyclical balance sheet risk.
News Sentiment
MKS Instruments is having a moment — and Wall Street is taking notice. The semiconductor equipment maker, which supplies critical components to chipmakers worldwide, is drawing increasingly bullish attention from analysts who see the stock potentially surging 49% to 52% from current levels, according to multiple recent reports. So what's driving the excitement? For starters, earnings estimates are moving in the right direction. A recent Zacks analysis titled 'Earnings Estimates Moving Higher for MKS (MKSI): Time to Buy?' signals that professional analysts are actively raising their profit forecasts for the company — typically a reliable leading indicator that a stock is about to outperform. Meanwhile, MKS just received two prestigious supplier awards from Zhen Ding Technology Group, a major player in circuit board manufacturing. These awards aren't just trophies — they signal that MKS is a deeply valued partner in Asia's booming electronics supply chain, making contract renewals and expanded business more likely. Adding fuel to the fire, MKS's Penang facility expansion is positioning the company to capture more business from the global wafer fabrication equipment boom — the wave of semiconductor factory construction sweeping the globe. 'MKS Instruments: Penang Expansion Boosts WFE Outlook Despite Margin Pressure' captures both the opportunity and the honest trade-off. Multiple outlets now classify MKSI as a 'Top Growth Stock for the Long-Term,' citing its exceptional earnings growth trajectory. The story here is a quality company at the center of the semiconductor buildout, with the wind at its back.
Risk Assessment
PRIMARY RISK: Cyclical semiconductor capex downturn. MKSI's D/E of 0.93 (73% above peer average) means any meaningful revenue compression will disproportionately hit earnings relative to less-leveraged peers. If WFE spending slows 20-25% (as happened in 2022-23), MKSI's FCF could compress toward $200-250M range, making the debt load more burdensome. SECONDARY RISK: Forward EPS growth miss. The 36.5% 5-year CAGR is the linchpin of the 'fair value' argument at PEG 1.22. Deceleration to ~20% would imply PEG ~2.2x at current P/E — triggering a de-rating that could push the stock toward $200-220. MITIGATION: $611M cash buffer provides 12-18 months of breathing room; FCF of $454M covers interest obligations comfortably in current conditions; position sizing at 3% limits portfolio impact. Stop loss at $248 (11.3% below entry price of $272.50) represents a logical technical support level and limits downside. UPSIDE CATALYST: Continued analyst EPS estimate revisions higher (already occurring per news), Penang/WFE cycle acceleration, and de-leveraging from strong FCF could re-rate the stock toward and beyond $345 analyst target.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is MKSI a halal stock?
No, MKS Inc. (MKSI) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for MKSI?
MKS Inc. (MKSI) has a Plutrex AI rating of 76.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is MKSI a good investment?
According to Plutrex AI, MKSI has a Buy rating (76.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in MKSI?
US stocks like MKSI can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in MKSI?
Plutrex AI identifies the main risks for MKSI by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.